License to Celgene. Subject to the terms and conditions of this Agreement, Prothena hereby grants to Celgene an exclusive right and license, with the right to grant sublicenses (through multiple tiers), under the Prothena IP to research, develop (including Develop), make (including Manufacture), have made (including have Manufactured), use, offer for sale, sell, import, Commercialize and otherwise exploit Licensed Antibodies and Licensed Products, including Diagnostic Products, in the Field in the Territory.
Appears in 6 contracts
Samples: Global License Agreement (Prothena Corp Public LTD Co), Global License Agreement (Prothena Corp Public LTD Co), u.s. License Agreement (Prothena Corp Public LTD Co)
